This trial is active, not recruiting.

Condition pancreatic cancer
Sponsor Asan Medical Center
Start date January 2009
End date November 2009
Trial size 70 participants
Trial identifier NCT00885248, 2008-0623


In suspecting pancreatic cancer, dynamic phase pancreatic CT is the most effective tool in diagnosis and staging. In addition, magnetic resolution image, endoscopic ultrasonography, endoscopic retrograde pancreatography, angiography can be performed.

After introduction of functional image, PET has been suggested in the role of diagnosis and staging of pancreatic cancer. Furthermore, recently fused images of PET and CT were available.

In this study, the researchers evaluate the role of integrated PET-CT in patients with pancreatic cancer and analysis the cost-effectiveness of the integrated PET-CT.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only
Time perspective prospective

Primary Outcomes

Staging of pancreatic cancer
time frame: 6 months after study start

Secondary Outcomes

Diagnosis of pancreatic cancer
time frame: 6 months after study start

Eligibility Criteria

Male or female participants from 18 years up to 75 years old.

Inclusion Criteria: - Pancreatic mass suspicious of pancreatic cancer - No comorbidity, expected life expectancy less than 6 months - Consent this study in letter Exclusion Criteria: - Refuse diagnostic and staging work-up

Additional Information

Official title Clinical Implication of Integrated PET-CT in the Patients With Pancreatic Cancer
Description Compared to dynamic phase pancreatic CT, integrated PET-CT will be evaluated for sensitivity, specificity and accuracy of diagnosing and staging pancreatic cancer while the gold standard for pancratic cancer is operative specimen. If the operation can't be performed, EUS-FNA of the pancreatic mass or lymph node and additional imaging modality will be preferred to laparotomy.
Trial information was received from ClinicalTrials.gov and was last updated in April 2009.
Information provided to ClinicalTrials.gov by Asan Medical Center.